Membrane dysfunction in Andersen-Tawil syndrome assessed by velocity recovery cycles

Muscle and Nerve

Volumn 46, Issue 2, 2012, Pages 193-203

  Tan, S Veronica ^a,b,c   Z'Graggen, Werner J ^d   Boërio, Delphine ^d   Rayan, Dipa L Raja ^a,b   Howard, Robin ^a,b,c   Hanna, Michael G ^a,b   Bostock, Hugh ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Andersen Tawil syndrome; Exercise tests; Muscle membrane potential; Muscle velocity recovery cycle; Tibialis anterior muscle

Indexed keywords

ADULT; ANDERSEN SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LATENT PERIOD; MALE; MEMBRANE DEPOLARIZATION; MUSCLE VELOCITY RECOVERY CYCLE; MUSCULOSKELETAL SYSTEM PARAMETERS; PRIORITY JOURNAL; REFRACTORY PERIOD; SARCOLEMMA; STIMULATION;

ADULT; ANDERSEN SYNDROME; CHANNELOPATHIES; ELECTRIC STIMULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUTATION; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SARCOLEMMA;

EID: 84864024065     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23293     Document Type: Article

References (41)

1. Klein R, Ganelin R, Marks JF, Usher P, Richards C. J Periodic paralysis with cardiac arrhythmia. J Pediatr 1963; 62: 371-385.
2. Andersen ED, Krasilnikoff PA, Overvad H. Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome? Acta Paediatr Scand 1971; 60: 559-564.
3. Tawil R, Ptacek LJ, Pavlakis SG, DeVivo DC, Penn AS, Ozdemir C, et al. Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol 1994; 35: 326-330.
4. Davies NP, Imbrici P, Fialho D, Herd C, Bilsland LG, Weber A, et al. Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation. Neurology 2005; 65: 1083-1089.
5. Sansone V, Griggs RC, Meola G, Ptacek LJ, Barohn R, Iannaccone S, et al. Andersen's syndrome: a distinct periodic paralysis. Ann Neurol 1997; 42: 305-312.
6. Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A, et al. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 2002; 110: 381-388.
7. Zhang L, Benson DW, Tristani-Firouzi M, Ptacek LJ, Tawil R, Schwartz PJ, et al. Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation 2005; 111: 2720-2726.
8. Donaldson MR, Jensen JL, Tristani-Firouzi M, Tawil R, Bendahhou S, Suarez WA, et al. PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome. Neurology 2003; 60: 1811-1816.
9. Andelfinger G, Tapper AR, Welch RC, Vanoye CG, George AL Jr, Benson DW. KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet 2002; 71: 663-668.
10. Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001; 105: 511-519.
11. Sansone V, Tawil R. Management and treatment of Andersen-Tawil syndrome (ATS). Neurotherapeutics 2007; 4: 233-237.
12. Tricarico D, Camerino DC. Recent advances in the pathogenesis and drug action in periodic paralyses and related channelopathies. Front Pharmacol 2011; 2: 8.
13. Zaza A, Rocchetti M, Brioschi A, Cantadori A, Ferroni A. Dynamic Ca2+-induced inward rectification of K+ current during the ventricular action potential. Circ Res 1998; 82: 947-956.
14. Matsuda H, Saigusa A, Irisawa H. Ohmic conductance through the inwardly rectifying K channel and blocking by internal Mg2+. Nature 1987; 325: 156-159.
15. Lopatin AN, Makhina EN, Nichols CG. Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature 1994; 372: 366-369.
16. Doi T, Makiyama T, Morimoto T, Haruna Y, Tsuji K, Ohno S, et al. A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of Andersen-Tawil syndrome. Circ Cardiovasc Genet 2011; 4: 253-260.
17. Lopes CM, Zhang H, Rohacs T, Jin T, Yang J, Logothetis DE. Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies. Neuron 2002; 34: 933-944.
18. Bendahhou S, Donaldson MR, Plaster NM, Tristani-Firouzi M, Fu YH, Ptacek LJ. Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome. J Biol Chem 2003; 278: 51779-51785.
19. Bendahhou S, Fournier E, Sternberg D, Bassez G, Furby A, Sereni C, et al. In vivo and in vitro functional characterization of Andersen's syndrome mutations. J Physiol 2005; 565: 731-741.
20. Miake J, Marban E, Nuss HB. Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression. J Clin Invest 2003; 111: 1529-1536.
21. Dhamoon AS, Jalife J. The inward rectifier current (IK1) controls cardiac excitability and is involved in arrhythmogenesis. Heart Rhythm 2005; 2: 316-324.
22. Kristensen M, Hansen T, Juel C. Membrane proteins involved in potassium shifts during muscle activity and fatigue. Am J Physiol Regul Integr Comp Physiol 2006; 290: R766-R772.
23. Fischer-Lougheed J, Liu JH, Espinos E, Mordasini D, Bader CR, Belin D, et al. Human myoblast fusion requires expression of functional inward rectifier Kir2.1 channels. J Cell Biol 2001; 153: 677-686.
24. Liu JH, Bijlenga P, Fischer-Lougheed J, Occhiodoro T, Kaelin A, Bader CR, et al. Role of an inward rectifier K+ current and of hyperpolarization in human myoblast fusion. J Physiol 1998; 510( Pt 2): 467-476.
25. Sacconi S, Simkin D, Arrighi N, Chapon F, Larroque MM, Vicart S, et al. Mechanisms underlying Andersen's syndrome pathology in skeletal muscle are revealed in human myotubes. Am J Physiol Cell Physiol 2009; 297: C876-C885.
26. McManis PG, Lambert EH, Daube JR. The exercise test in periodic paralysis. Muscle Nerve 1986; 9: 704-710.
27. Tan SV, Matthews E, Barber M, Burge JA, Rajakulendran S, Fialho D, et al. Refined exercise testing can aid dna-based diagnosis in muscle channelopathies. Ann Neurol 2011; 69: 328-340.
28. Katz JS, Wolfe GI, Iannaccone S, Bryan WW, Barohn RJ. The exercise test in Andersen syndrome. Arch Neurol 1999; 56: 352-356.
29. Z'graggen WJ, Bostock H. Velocity recovery cycles of human muscle action potentials and their sensitivity to ischemia. Muscle Nerve 2009; 39: 616-626.
30. Mihelin M, Trontelj JV, Stalberg E. Muscle fiber recovery functions studied with double pulse stimulation. Muscle Nerve 1991; 14: 739-747.
31. Stalberg E. Propagation velocity in human muscle fibers in situ. Acta Physiol Scand Suppl 1966; 287: 1-112.
32. Bergmans J. The negative after potential of human muscle fibers. Arch Int Physiol Biochim 1971; 79: 187-188.
33. Barrett EF, Barrett JN. Intracellular recording from vertebrate myelinated axons: mechanism of the depolarizing afterpotential. J Physiol 1982; 323: 117-144.
34. Frank GB. Negative after-potential of frog's skeletal muscle. J Neurophysiol 1957; 20: 602-614.
35. Z'graggen WJ, Aregger F, Farese S, Humm AM, Baumann C, Uehlinger DE, et al. Velocity recovery cycles of human muscle action potentials in chronic renal failure. Clin Neurophysiol 2010; 121: 874-881.
36. Zaritsky JJ, Redell JB, Tempel BL, Schwarz TL. The consequences of disrupting cardiac inwardly rectifying K(+) current (I(K1)) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes. J Physiol 2001; 533: 697-710.
37. Freygang WH Jr, Goldstein DA, Hellam DC, Peachey LD. The relation between the late after-potential and the size of the transverse tubular system of frog muscle. J Gen Physiol 1964; 48: 235-263.
38. Hino N. Some properties of late after-potential in frog skeletal muscle fiber. Jpn J Physiol 1977; 27: 235-250.
39. Z'graggen WJ, Brander L, Tuchscherer D, Scheidegger O, Takala J, Bostock H. Muscle membrane dysfunction in critical illness myopathy assessed by velocity recovery cycles. Clin Neurophysiol 2011; 122: 834-841.
40. Z'graggen WJ, Troller R, Ackermann KA, Humm AM, Bostock H. Velocity recovery cycles of human muscle action potentials: repeatability and variability. Clin Neurophysiol 2011; 122: 2294-2299.
41. Humm AM, Bostock H, Troller R, Z'graggen WJ. Muscle ischaemia in patients with orthostatic hypotension assessed by velocity recovery cycles. J Neurol Neurosurg Psychiatry 2011; 82: 1394-1398.